Literature DB >> 2377316

Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms.

S Folkard1, J Arendt, M Aldhous, H Kennett.   

Abstract

The pineal hormone melatonin (N-acetyl-5-methoxytryptamine) is normally secreted at night: in animals it serves to transmit information about light-dark cycles to body physiology Suitable timed administration will alleviate 'jet-lag' severity ratings in humans, the major effect being to improve sleep. It has been suggested that this may be mediated by melatonin re-entraining the endogenous circadian oscillator. We have examined this possibility by feeding melatonin to a blind individual (HK) with a free-running temperature rhythm and a pronounced 35-day cycle in his ability to fall asleep at 'normal' times. Our results show a clear stabilizing effect of melatonin on sleep onset time with elimination of day time sleep, but no entrainment of rectal temperature or urinary cortisol rhythms. Thus melatonin may act on the timing mechanism of sleep onset, rather than as a entrainer of all circadian rhythms. It may well help shiftworkers to sleep at inappropriate phases of their circadian oscillators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2377316     DOI: 10.1016/0304-3940(90)90302-p

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

Review 1.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Light, melatonin and the sleep-wake cycle.

Authors:  G M Brown
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

3.  GA-based Design Algorithms for the Robust Synthetic Genetic Oscillators with Prescribed Amplitude, Period and Phase.

Authors:  Bor-Sen Chen; Po-Wei Chen
Journal:  Gene Regul Syst Bio       Date:  2010-05-24

Review 4.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

5.  A Nationwide Cross-Sectional Survey of Sleep-Related Problems in Japanese Visually Impaired Patients: Prevalence and Association with Health-Related Quality of Life.

Authors:  Norihisa Tamura; Taeko Sasai-Sakuma; Yuko Morita; Masako Okawa; Shigeru Inoue; Yuichi Inoue
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 6.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

8.  Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders.

Authors:  M L Laakso; L Leinonen; T Hätönen; A Alila; H Heiskala
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

9.  Structural requirements at the melatonin receptor.

Authors:  D Sugden; N W Chong; D F Lewis
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 10.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.